VELABS THERAPEUTICS

velabs-therapeutics-logo

Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies. Their high-throughput screening platform allows for testing millions of correctly paired fully natural IgGs from humans and mice for therapeutic effects, rather than just for binding. Rare functional hits are readily identified, which might be laborious or even impossible using other technologies. Velabs’ antibody screens can thus significantly and competitively shorten pre-clinical development.

#SimilarOrganizations #People #Website #More

VELABS THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2017-01-01

Address:
Heidelberg, Baden-Wurttemberg, Germany

Country:
Germany

Website Url:
http://www.veraxa.de

Total Employee:
11+

Status:
Active

Contact:
+49 6221 387 8194

Email Addresses:
info@velabs-therapeutics.com

Total Funding:
3 M EUR

Technology used in webpage:
SPF IPv6 Microsoft Exchange Online Office 365 Mail Pound Sterling Japanese Yen Strato Strato DNS


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

cellsway-logo

Cellsway

Cellsway is developing liquid biopsy platform which uses a simple blood sample for monitoring cancer.

microbrain-biotech-logo

MicroBrain Biotech

MicroBrain Biotech develops and designs microfluidic devices and Nerve-on-Chip (reconstructed neuron networks at the micron scale).

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

scartec-therapeutics-logo

ScarTec Therapeutics

ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

veramaris-logo

Veramaris

Veramaris is a producer of omega-3 fatty acids for animal nutrition from microalgae.

veraxa-biotech-logo

VERAXA Biotech

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.


Current Advisors List

edward-lemke_image

Edward Lemke Scientific Advisor @ Velabs Therapeutics
Advisor

christoph-merten_image

Christoph Merten Scientific Advisor @ Velabs Therapeutics
Advisor

Current Employees Featured

martin-haase_image

Martin Haase
Martin Haase Chief Financial Officer & Executive, Strategy @ Velabs Therapeutics
Chief Financial Officer & Executive, Strategy

edward-lemke_image

Edward Lemke
Edward Lemke Co-Founder @ Velabs Therapeutics
Co-Founder

christoph-antz_image

Christoph Antz
Christoph Antz Co-Founder & Chief Executive Officer @ Velabs Therapeutics
Co-Founder & Chief Executive Officer
2017-12-01

christine-köhler_image

Christine Köhler
Christine Köhler Dipl.-Ing., Co-Founder, Head of Biotechnology RD, Antibody Production @ Velabs Therapeutics
Dipl.-Ing., Co-Founder, Head of Biotechnology RD, Antibody Production

christoph-merten_image

Christoph Merten
Christoph Merten Co-Founder & Chief Scientific Officer @ Velabs Therapeutics
Co-Founder & Chief Scientific Officer

Founder


christine-köhler_image

Christine Köhler

christoph-antz_image

Christoph Antz

christoph-merten_image

Christoph Merten

edward-lemke_image

Edward Lemke

Official Site Inspections

http://www.veraxa.de

  • Host name: static.72.175.47.78.clients.your-server.de
  • IP address: 78.47.175.72
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Velabs Therapeutics"

About us - Veraxa

VERAXA is a privately held company. Main shareholder is the Swiss company Xlife Sciences AG. Other shareholders are the European Molecular Biology Laboratory (EMBL) and its technology …See details»

Veraxa

Next-generation ADCs and novel antibody formats will take safety to the next level. With a strong foundation in ADCs and our lead program in clinical studies in AML. The VERAXA team is …See details»

Our approach - Veraxa

VERAXA is the only company with an integrated approach that combines functional antibody screening with bioconjugation technology. We harvest our suite of innovative technologies to …See details»

VERAXA Biotech GmbH - LinkedIn

Through biochemical and technological innovation, we strive to transform the way antibodies and antibody-drug conjugates (ADCs) are created to develop more effective and safe therapies for...See details»

VERAXA Biotech GmbH - BIO International Convention | BIO

VERAXA is an early-stage biotechnology company with game-changing antibody discovery, screening and conjugation technology yielding the most optimized Antibody Drug Conjugates …See details»

VERAXA - EMBLEM Technology Transfer GmbH

VERAXA combines game changing technologies developed at the EMBL Heidelberg to solve the most prominent challenges in antibody drug development. The VERAXA Biotech Company …See details»

VERAXA Biotech - Crunchbase Company Profile & Funding

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation. A droplet-based microfluidics platform that combines …See details»

Veraxa Biotech - Org Chart, Teams, Culture & Jobs - The Org

View Veraxa Biotech's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

VERAXA Biotech - VentureRadar

Develops droplet-based microfluidic screening and protein conjugation technology for rapid generation of antibodies, focusing on oncology and precision medicine. Partners with global …See details»

VERAXA Biotech GmbH - Xlife Sciences

Veraxa Biotech AG focuses on the development of antibody-drug conjugates through an innovative click chemistry approach and the microfluidic screening of functional antibodies. …See details»

Veraxa Company Profile 2024: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Veraxa. Use the PitchBook Platform to explore the full profile.See details»

Veraxa

HEIDELBERG, Germany, January 29, 2024 -- VERAXA Biotech GmbH, an emerging leader in designing novel cancer immunotherapies, today provided an update on its pipeline …See details»

VERAXA Biotech - Funding, Financials, Valuation & Investors

Dec 29, 2023 · VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.See details»

VERAXA Biotech AG übernimmt Synimmune GmbH zur …

Dec 29, 2023 · Die VERAXA Biotech AG hat den FLYSYN-Antikörper von der Synimmune GmbH, einem Portfoliounternehmen von Xlife Sciences AG, über einen Aktiendeal erworben. Der …See details»

VERAXA Biotech GmbH – BioRN – Life Science Cluster Rhine-Neckar

VERAXA Biotech GmbH; September 10, 2024 . VERAXA Biotech GmbH. Go back Share this article: Original News Our latest News discover more . bioRN annual report 2024. read more . …See details»

Veraxa

HEIDELBERG, Germany, May 21, 2024 -- VERAXA Biotech GmbH, an emerging leader in designing novel cancer therapies, announced today the formation of a Clinical Advisory Board …See details»

velabs (VERAXA Biotech GmbH) - Startbase

Headquarter: Heidelberg, DE; Official Website: velabs-therapeutics.com; On Social Media: Legal Entity: VERAXA Biotech GmbH Location: SaarlandSee details»

VERAXA Biotech and Quadira Biosciences Enter Partnership on …

Jun 14, 2021 · VERAXA Biotech is a leading pioneer of microfluidic technology for the ultra-fast screening of functional antibodies. The company has developed superior microfluidic hardware …See details»

Veraxa

VERAXA is a preferred license and cooperation partner of global biotech and pharma industries. Contact. VERAXA Biotech GmbH Dr. Christoph Antz CEO Meyerhofstrasse 1 69117 …See details»

Working at Veraxa Biotech - Glassdoor

See what employees say it's like to work at Veraxa Biotech. Salaries, reviews, and more - all posted by employees working at Veraxa Biotech.See details»

linkstock.net © 2022. All rights reserved